Chatter with BNC | Kevin O'Brien, President of Merz Therapeutics
Podcast dedicated to all things business in North Carolina. We talk to the state's leaders in healthcare, manufacturing, education and more about their business, passions and lives in an entertaining and informative manner.
Welcome to Chatter with
BNC, Business North Carolina's weekly podcast,
serving up interviews with some of the Tar Heel State's most
interesting people.
Today's episode features an interview with Kevin
O’Brien. O'Brien serves as president of North America for Merz
Therapeutics, where he leads commercial strategy and execution,
including field sales, managed markets, medical affairs, marketing
and operations, across the U.S. and Canada. Since joining Merz in
2017, he has overseen the U.S. FDA approval of Merz’s
neuromodulator for the treatment of sialorrhea (excessive drooling)
and as a first-line treatment for blepharospasm, two debilitating
conditions associated with neurological conditions, including
Parkinson’s disease, ALS and cerebral palsy.
About the Podcast
Welcome to Chatter with BNC, Business North Carolina magazine's weekly podcast, serving up interviews with some of the Tar Heel State's most interesting people.